45 Biggest Movers From Yesterday

Gainers

• Entera Bio Ltd. ENTX shares surged 44.8% to close at $6.50 on Wednesday after the company reported topline Phase 2 bone mineral density data for EB613.
• First Advantage Corporation FA gained 31.3% to settle at $19.70 after the company priced its IPO at $15 per share.
• Bellerophon Therapeutics, Inc. BLPH jumped 30.4% to close at $5.32. Hearing Brookline Capital initiated coverage on the stock with a Buy rating and $26 price target.
• Orphazyme A/S ORPH gained 24.6% to settle at $7.44. Orphazyme announced Goldman Sachs aggregate holding of shares and financial instruments in the company increased to 5.8% as of June 16, 2021 and was reduced to less than 5% as of June 17, 2021.
• Moxian, Inc. MOXC shares gained 22% to close at $20.09.
• Loop Industries, Inc. LOOP climbed 20.6 % to settle at $15.90. Loop Industries announced plans to form a strategic partnership with SK global chemical Co. Ltd to bring sustainable and circular plastics to the Asian market.
• Auddia Inc. AUUD gained 18.5% to close at $3.58.
• Clearside Biomedical, Inc. CLSD rose 18.5% to close at $5.38.
• SeaChange International, Inc. SEAC surged 18.1% to settle at $1.24 after it was disclosed company director Robert Pons bought 100,000 shares at an average price of $1.06 per share.
• Vertex Energy, Inc. VTNR rose 18% to close at $8.67.
• Aspen Group, Inc. ASPU gained 17.5% to settle at $7.00 after the company reported a 35% year-over-year increase in Q4 sales and a 21% increase in bookings.
• Target Hospitality Corp. TH surged 17% to close at $4.54 after Oppenheimer upgraded the stock from Perform to Outperform and announced a $6 price target.
• Research Frontiers Incorporated REFR surged 16.2% to close at $2.44.
• HUTCHMED (China) Limited HCM gained 16% to close at $30.02. AstraZeneca and HUTCHMED's Orpathys (savolitinib) has been granted conditional approval in China to treat patients with non-small cell lung cancer.
• BBQ Holdings, Inc. BBQ gained 15.5% to close at $16.88.
• Pennsylvania Real Estate Investment Trust PEI climbed 15% to close at $2.69.
• Perion Network Ltd. PERI jumped 15% to close at $19.47.
• Evaxion Biotech A/S EVAX gained 14.4% to close at $7.00.
• SELLAS Life Sciences Group, Inc. SLS surged 13.3% to close at $13.42. SELLAS Life Sciences will join Russell Microcap Index, effective Jun. 28.
• GTT Communications, Inc. GTT rose 13.2% to close at $2.48.
• NanoViricides, Inc. NNVC jumped 12.3% to close at $4.76.
• UP Fintech Holding Limited TIGR gained 10.6% to close at $26.62.
• Ideanomics, Inc. IDEX rose 10.5% to close at $3.15. Ideanomics recently acquired premium zero-emission electric tractor manufacturer and distributor Solectrac Inc.
• Acasti Pharma Inc. ACST gained 10.4% to close at $0.5964 after jumping 10% on Tuesday. The company reported a narrower FY21 loss.
• Tenax Therapeutics, Inc.. TENX rose 9.5% to close at $2.08 after Stuart Rich disclosed a 16.84% active stake In the company.
• The OLB Group, Inc. OLB gained 8.9% to close at $5.39. The OLB Group announced a new NFT solutions platform to help companies.
• SkyWater Technology, Inc. SKYT rose 7.9% to close at $29.00.
• Tiziana Life Sciences PLC TLSA rose 4.8% to close at $2.41 after the company reported collaboration agreement with FHI Clinical to conduct a Phase 2 Clinical Trial for treating hospitalized severe COVID-19 Patients with intranasal foralumab, a fully human anti-CD3 monoclonal antibody.
• XPeng Inc. XPEV rose 4.1% to settle at $41.61 after Reuters reported that the company received approval to list on Hong Kong Exchange.

Check out these big penny stock gainers and losers

Losers

• Gemini Therapeutics, Inc. GMTX shares tumbled 31.5% to close at $6.69 on Wednesday after the company announced initial data from its Phase 2a ReGAtta study of GEM103 in patients with secondary to dry age-related macular degeneration.
• Torchlight Energy Resources, Inc. TRCH dipped 29.7% to settle at $4.92. Torchlight Energy Resources shares dipped around 30% on Tuesday after the company announced an amendment to its At-The-Market offering deal with Roth Capital. The offering was raised from $100 million to $250 million.
• Alfi, Inc. ALF slipped 26.3% to close at $12.01. ALFI shares jumped 108% on Tuesday after the company announced a $2 million buyback.
• Second Sight Medical Products, Inc. EYES dropped 18.9% to settle at $5.15 after the company reported the pricing of its underwritten public offering of 10,000,000 shares at $5.00 per share.
• Millendo Therapeutics, Inc. MLND shares dipped 17.4% to close at $1.14. Tempest Therapeutics and Millendo Therapeutics reported approval of merger.
• Keros Therapeutics, Inc. KROS fell 15.2% to close at $44.57 after the company disclosed preliminary results from Phase 2 clinical trial evaluating KER-050.
• BioXcel Therapeutics, Inc. BTAI dropped 14% to close at $31.68 as the company priced 3,155,000 share common stock offering at $31.70 per share.
• Global Self Storage, Inc. SELF declined 13.4% to settle at $5.23 after the company priced its $6.0 million underwritten public offering of common stock.
• Patterson Companies, Inc. PDCO fell 11.9% to close at $30.97 after the company reported worse-than-expected Q4 earnings and issued weak FY22 EPS guidance.
• Score Media and Gaming Inc. SCR dropped 11.2% to settle at $21.55. The Canadian Senate has passed Bill C-218 approving single event sports betting in the country. The bill received 57 votes for, 20 against and five abstained votes.
• Impel NeuroPharma, Inc. IMPL tumbled 10.2% to close at $7.35.
• Taiwan Liposome Company, Ltd. TLC fell 9.4% to settle at $5.90.
• OneSpaWorld Holdings Limited OSW dipped 9% to close at $10.20 after the company announced a proposed underwritten secondary public offering of its common shares on behalf of Steiner Leisure Limited and certain affiliates of OneSpaWorld's directors.
• Capricor Therapeutics, Inc. CAPR dipped 8.7% to settle at $5.22. Capricor Therapeutics shares fell on Monday after a filing from the company showed registration for a $75 million common stock shelf offering.
• MeaTech 3D Ltd. MITC fell 6.8% to close at $7.16 after gaining over 8% on Tuesday.
• Adial Pharmaceuticals, Inc. ADIL fell 6.1% to close at $2.94. Adial Pharmaceuticals gained 9% on Tuesday after the company announced plans to enter genetic testing market following allowance of U.S. patent for genetic diagnostic test.